No. BILLERICA, Mass.--(BUSINESS WIRE)--Lantheus Medical Imaging, Inc., a global leader in developing, manufacturing and distributing innovative diagnostic imaging agents, today announced it has been awarded a three-year supplier contract with Premier Purchasing Partners, L.P., the group purchasing unit of the Premier healthcare alliance, for its radiopharmaceutical imaging agents. Effective January 1, 2012 through December 31, 2014, the new radiopharmaceutical products agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for Cardiolite® (Kit for the Preparation of Technetium Tc99m Sestamibi for Injection), Gallium 67 (Gallium Citrate Ga67 Injections), Neurolite® (Kit of the Preparation of Technetium Tc99m Bicisate for Injection), TechneLite® (Technetium Tc99m Generator), 201 Thallium (Thallous Chloride Tl201 Injection) and Xenon 133 (Xenon Xe 133 Gas).
